Production (Stage)
Vigil Neuroscience, Inc.
VIGL
$7.89
$0.010.13%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -22.41M | -23.83M | -19.26M | -21.23M | -19.94M |
| Total Depreciation and Amortization | 124.00K | 113.00K | 114.00K | 113.00K | 113.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2.78M | 2.60M | 2.60M | 2.53M | 2.23M |
| Change in Net Operating Assets | -4.38M | 2.97M | 20.85M | 3.08M | -4.29M |
| Cash from Operations | -23.89M | -18.14M | 4.30M | -15.50M | -21.88M |
| Capital Expenditure | -285.00K | 0.00 | 0.00 | -5.00K | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 23.51M | 7.83M | -16.58M | 1.05M | 16.47M |
| Cash from Investing | 23.23M | 7.83M | -16.58M | 1.04M | 16.47M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 13.27M | 4.44M | 51.00K | 9.00K | 5.18M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | 0.00 | 19.81M | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 13.27M | 4.44M | 19.86M | 9.00K | 5.18M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 12.60M | -5.88M | 7.58M | -14.45M | -231.00K |